2016 Q4 Form 10-Q Financial Statement

#000156459016027956 Filed on November 07, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2015 Q4
Revenue $11.96M $5.268M $17.00K
YoY Change 70264.71% 13407.69% -63.83%
Cost Of Revenue $2.300M $845.0K $2.500M
YoY Change -8.0%
Gross Profit $10.26M $4.423M -$2.500M
YoY Change -510.32%
Gross Profit Margin 85.75% 83.96% -14705.88%
Selling, General & Admin $57.70M $50.50M $22.60M
YoY Change 155.31% 148.77% 117.31%
% of Gross Profit 562.49% 1141.76%
Research & Development $30.20M $25.81M $20.50M
YoY Change 47.32% 37.82% 12.64%
% of Gross Profit 294.4% 583.61%
Depreciation & Amortization $630.0K $610.0K $130.0K
YoY Change 384.62% 408.33% 116.67%
% of Gross Profit 6.14% 13.79%
Operating Expenses $87.90M $25.81M $43.10M
YoY Change 103.94% -33.88% 50.7%
Operating Profit -$77.64M -$72.40M -$45.60M
YoY Change 70.27% 85.65%
Interest Expense $900.0K $786.0K $100.0K
YoY Change 800.0% 754.35% -50.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$77.40M -$71.60M -$45.50M
YoY Change 70.11% 84.06% 60.21%
Income Tax $1.300M $300.0K
% Of Pretax Income
Net Earnings -$78.70M -$71.61M -$45.78M
YoY Change 71.89% 84.07% 61.4%
Net Earnings / Revenue -657.88% -1359.4% -269317.65%
Basic Earnings Per Share
Diluted Earnings Per Share -$649.3K -$609.4K -$452.6K
COMMON SHARES
Basic Shares Outstanding 121.1M 100.9M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2016 Q3 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $529.0M $588.9M $215.1M
YoY Change 145.91% 144.67% -33.29%
Cash & Equivalents $163.6M $153.7M $102.1M
Short-Term Investments $365.4M $435.2M $113.0M
Other Short-Term Assets $7.500M $5.100M $2.200M
YoY Change 240.91% 155.0% 83.33%
Inventory $4.175M $4.300M
Prepaid Expenses $7.546M
Receivables $5.903M $3.800M
Other Receivables $1.200M $1.400M
Total Short-Term Assets $547.9M $603.5M $219.0M
YoY Change 150.19% 148.51% -32.54%
LONG-TERM ASSETS
Property, Plant & Equipment $3.081M $3.200M $2.203M
YoY Change 39.85% 54.74% 298.37%
Goodwill
YoY Change
Intangibles $7.015M $7.385M
YoY Change
Long-Term Investments
YoY Change
Other Assets $785.0K $3.400M $329.0K
YoY Change 138.6% 739.51% 14.63%
Total Long-Term Assets $13.26M $13.90M $2.907M
YoY Change 356.0% 462.07% 246.07%
TOTAL ASSETS
Total Short-Term Assets $547.9M $603.5M $219.0M
Total Long-Term Assets $13.26M $13.90M $2.907M
Total Assets $561.2M $617.4M $221.9M
YoY Change 152.89% 151.67% -31.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.912M $2.800M $1.672M
YoY Change 133.97% 27.04% -17.06%
Accrued Expenses $36.03M $34.40M $20.23M
YoY Change 78.1% 121.49% 46.4%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $42.59M $39.10M $21.90M
YoY Change 94.43% 120.47% 38.32%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $200.0K $200.0K $200.0K
YoY Change 0.0% 0.0% 100.0%
Total Long-Term Liabilities $157.0K $200.0K $232.0K
YoY Change -32.33% -16.32% 71.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $42.59M $39.10M $21.90M
Total Long-Term Liabilities $157.0K $200.0K $232.0K
Total Liabilities $42.74M $39.30M $22.13M
YoY Change 93.11% 118.65% 38.61%
SHAREHOLDERS EQUITY
Retained Earnings -$934.0M -$662.6M
YoY Change 40.96% 33.01%
Common Stock $1.452B $10.00K
YoY Change 14522740.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $518.4M $578.1M $199.8M
YoY Change
Total Liabilities & Shareholders Equity $561.2M $617.4M $221.9M
YoY Change 152.89% 151.67% -31.82%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2015 Q4
OPERATING ACTIVITIES
Net Income -$78.70M -$71.61M -$45.78M
YoY Change 71.89% 84.07% 61.4%
Depreciation, Depletion And Amortization $630.0K $610.0K $130.0K
YoY Change 384.62% 408.33% 116.67%
Cash From Operating Activities -$61.19M -$49.26M -$34.73M
YoY Change 76.19% 54.66% 95.11%
INVESTING ACTIVITIES
Capital Expenditures -$250.0K -$470.0K -$290.0K
YoY Change -13.79% 147.37% 222.22%
Acquisitions
YoY Change
Other Investing Activities $69.39M -$154.4M $57.02M
YoY Change 21.69% -1919.08% 40.55%
Cash From Investing Activities $69.14M -$154.9M $56.72M
YoY Change 21.9% -1964.02% 40.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $215.9M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.980M 226.1M 9.330M
YoY Change -57.34% 19907.08% 232.03%
NET CHANGE
Cash From Operating Activities -61.19M -49.26M -34.73M
Cash From Investing Activities 69.14M -154.9M 56.72M
Cash From Financing Activities 3.980M 226.1M 9.330M
Net Change In Cash 11.93M 21.92M 31.32M
YoY Change -61.91% -197.81% 22.87%
FREE CASH FLOW
Cash From Operating Activities -$61.19M -$49.26M -$34.73M
Capital Expenditures -$250.0K -$470.0K -$290.0K
Free Cash Flow -$60.94M -$48.79M -$34.44M
YoY Change 76.95% 54.11% 94.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Costs And Expenses
CostsAndExpenses
199953000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-38998000
CY2016Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
786000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-38906000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2219000
CY2016Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7385000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
375000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
329000
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
121113846
CY2015Q4 us-gaap Assets
Assets
221896000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1672000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20230000
CY2016Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1876000
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
862327000
CY2016Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
845000
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18729000
CY2015Q3 us-gaap Costs And Expenses
CostsAndExpenses
39037000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
128793000
us-gaap License Costs
LicenseCosts
723000
CY2016Q3 us-gaap Costs And Expenses
CostsAndExpenses
77667000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-72399000
us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
-758000
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.39
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.69
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
117497000
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
100756000
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
328000
us-gaap Net Income Loss
NetIncomeLoss
-192697000
us-gaap Net Income Loss
NetIncomeLoss
-118659000
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.61
us-gaap Depreciation
Depreciation
583000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1371000
CY2016Q3 us-gaap License Costs
LicenseCosts
475000
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25813000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
65688000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-71613000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.18
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
100436000
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
2000000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
3000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8945000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61854000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70799000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
287000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
186000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
798000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
114063000
CY2015Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
34000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
524000
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
118000
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-71286000
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38872000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
14090000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1571000
us-gaap Share Based Compensation
ShareBasedCompensation
39847000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1876000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-145000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1902000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
615000
us-gaap Depreciation
Depreciation
519000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-5000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3839000
us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
-253000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3503000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2887000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
782000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
646000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
994000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
144000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-55000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
104000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-147219000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-87073000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
592868000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
215926000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
271061000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
308619000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
8000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1257000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1848000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-331064000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
90845000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
515506000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5170000
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
14320000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
529826000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5170000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
51541000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5722000
CY2016Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
9488000
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4508000
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">10. Recent Accounting Pronouncements</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued authoritative guidance related to accounting for credit losses on financial instruments that changes the impairment model for most financial assets and certain other instruments. For trade receivables and other instruments, entities will be required to use a new forward-looking expected loss model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. This guidance is effective for annual reporting periods beginning after December 15, 2019, including interim periods within those years, with early adoption permitted only as of annual reporting periods beginning after December 15, 2018. The Company is currently evaluating the impact of the adoption of this guidance on the Company&#8217;s consolidated financial statements.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March, April, and May 2016, the FASB issued updates to its authoritative guidance for revenue from contracts with customers. The updates clarify certain aspects of the revenue guidance, including but not limited to, the implementation guidance on principal versus agent considerations, the licensing implementation guidance, identification of performance obligations, assessment of the collectability criterion, presentation of sales taxes and other similar taxes, and measurement of noncash consideration. The authoritative guidance for revenue from contracts with customers to which these updates apply is effective for annual reporting periods beginning after December 15, 2017, with early adoption permitted only as of annual reporting periods beginning after December 15, 2016. Companies may use either a full retrospective or a modified retrospective approach to adopt this guidance. The Company is continuing to evaluate which transition approach to use and its impact, if any, on its consolidated financial statements.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2016, the FASB issued authoritative guidance related to accounting for employee share-based compensation which is intended to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, classification on the statement of cash flows, and accounting for forfeitures. This guidance is effective for annual reporting periods beginning after December 15, 2016, including interim periods within those years. The Company is currently evaluating the impact of the adoption of this guidance on the Company&#8217;s consolidated financial statements.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2016, the FASB issued authoritative guidance related to accounting for leases. This accounting guidance will require a lessee to recognize a lease liability and a right-of-use asset for all leases with lease terms of more than 12 months. This guidance is effective for annual reporting periods beginning after December 15, 2018, including interim periods within those years, and early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on the Company&#8217;s consolidated financial statements.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2014, the FASB issued authoritative accounting guidance related to an entity&#8217;s ability to continue as a going concern. This guidance explicitly requires management to assess an entity&#8217;s ability to continue as a going concern, and to provide related footnote disclosures in certain circumstances. The new standard is effective for annual reporting periods ending after December 15, 2016, and for annual periods and interim periods thereafter, with early adoption permitted. The Company early adopted this guidance in the first quarter of 2016 with no impact to its consolidated financial statements or related disclosures.</p></div>
CY2016Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3170000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1195000
CY2016Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
434658000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31292000
CY2016Q2 acad Regulatory Milestone Payment
RegulatoryMilestonePayment
8000000
CY2016Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8000000
CY2016Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
369000
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
369000
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1500000
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1500000
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1500000
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1500000
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1100000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14463000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12309000
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14009000
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9265000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
39847000
CY2016Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
134900000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2016Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2157000
CY2016Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
2144000
CY2016Q3 acad Accrued Clinical Development Services
AccruedClinicalDevelopmentServices
9866000
CY2015Q4 acad Accrued Clinical Development Services
AccruedClinicalDevelopmentServices
8805000
CY2016Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11921000
CY2016Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
562000
CY2016Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
40000
CY2015Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
112996000
CY2015Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
12000
CY2015Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
14000
CY2015Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
213059000
CY2016Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
215900000
CY2016Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6969696
CY2016Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
281600000
CY2016Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10344827
CY2016Q2 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
14300000
CY2016Q2 acad Prior Stockholders Percentage Of Equity Holding
PriorStockholdersPercentageOfEquityHolding
0.10

Files In Submission

Name View Source Status
0001564590-16-027956-index-headers.html Edgar Link pending
0001564590-16-027956-index.html Edgar Link pending
0001564590-16-027956.txt Edgar Link pending
0001564590-16-027956-xbrl.zip Edgar Link pending
acad-10q_20160930.htm Edgar Link pending
acad-20160930.xml Edgar Link completed
acad-20160930.xsd Edgar Link pending
acad-20160930_cal.xml Edgar Link unprocessable
acad-20160930_def.xml Edgar Link unprocessable
acad-20160930_lab.xml Edgar Link unprocessable
acad-20160930_pre.xml Edgar Link unprocessable
acad-ex101_248.htm Edgar Link pending
acad-ex102_247.htm Edgar Link pending
acad-ex311_7.htm Edgar Link pending
acad-ex312_11.htm Edgar Link pending
acad-ex321_6.htm Edgar Link pending
acad-ex322_12.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending